![glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting
Description
So far most of the trials in this area have been small and led by academic investigators
![glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting](https://i0.wp.com/www.sarahhormachea.com/wp-content/uploads/2025/04/Slide8.png?ssl=1)
Alfaris, N., et al
![glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting](https://www.mdpi.com/ijms/ijms-27-02853/article_deploy/html/images/ijms-27-02853-g002-550.jpg)
Albiglutide was associated with fewer hypoglycemic events and moderate weight loss, but Albiglutide based on fusion protein technology produced more antibodies due to its functional protein domain
![glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/721135/fendo-12-721135-HTML/image_m/fendo-12-721135-g001.jpg)
Two popular options for the treatment of obesity are bariatric surgery (e.g
![glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting](https://www.researchgate.net/publication/371461642/figure/fig2/AS:11431281210340311@1702043944953/Mechanisms-of-action-of-GLP-1RA.jpg)
W.MannJ
![glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting](https://ars.els-cdn.com/content/image/1-s2.0-S1550413118301797-gr2.jpg)
A weekly formulation of exenatide called Bydureon was approved in 2012
![glp-1 agonist weight loss mechanism of action of [25] GLP-1 Therapy Part 1: Setting](https://ars.els-cdn.com/content/image/1-s2.0-S0753332218327537-gr2.jpg)
